- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 209/16 - Tryptamines
Patent holdings for IPC class C07D 209/16
Total number of patents in this class: 613
10-year publication summary
|
14
|
15
|
6
|
9
|
11
|
35
|
64
|
115
|
86
|
78
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Caamtech, Inc. | 146 |
80 |
| Enveric Biosciences Canada Inc. | 62 |
33 |
| Mindset Pharma Inc. | 57 |
30 |
| Compass Pathfinder Limited | 99 |
25 |
| Cybin IRL Limited | 62 |
19 |
| Beckley Psytech Limited | 36 |
18 |
| Cybin UK Ltd | 39 |
18 |
| Psilo Scientific Ltd. | 54 |
14 |
| Gilgamesh Pharmaceuticals, Inc. | 58 |
12 |
| Terran Biosciences, Inc. | 95 |
12 |
| Atai Therapeutics, Inc. | 68 |
12 |
| GH Research Ireland Limited | 77 |
9 |
| MagicMed Industries Inc. | 9 |
8 |
| H. Lundbeck A/S | 1249 |
7 |
| Small Pharma Limited | 16 |
7 |
| Zylorion Health Inc. | 10 |
7 |
| Mydecine Innovations Group Inc. | 33 |
6 |
| Psilera Inc. | 11 |
6 |
| Canna Chemistries LLC | 11 |
6 |
| Psylo Pty Ltd | 16 |
6 |
| Other owners | 278 |